glp-1 semaglutide compound Dosage Chart for Weight Loss & Dosing Guide Semaglutide Dosage Chart: Ozempic vs

Novo Nordisk reported the results from the STEP 1 extension trial on the impact of treatment withdrawal, which found that one year after withdrawal of once-weekly subcutaneous semaglutide 2.4 mg and lifestyle intervention, participants regained two-thirds of their prior weight loss

And thats no small thing

While this persistence rate is a marked improvement over the 10% observed for obesity-indicated GLP-1s, it still leaves 76% of potential demand unrealized

Beyond just numbers, this peptide cheat sheet also highlights the incredible range of benefits

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment

Doctors also struggle to get their patients prescriptions for these medications: according to Cure's specialty physician survey white paper, published in January, 89 percent faced coverage challenges when prescribing GLP-1s beyond obesity and diabetes